| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/13/1995 | WO1995000501A3 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 04/13/1995 | CA2173495A1 Treatment of tumors by genetic transformation of tumor cells with genes encoding negative selective markers and cytokines |
| 04/13/1995 | CA2173234A1 Pyrimidinyl-glutamic acid derivatives |
| 04/13/1995 | CA2173217A1 Novel receptor-type phosphotyrosine phosphatase-sigma |
| 04/13/1995 | CA2172415A1 Boronated metalloporphyrins and therapeutic methods |
| 04/13/1995 | CA2171465A1 Highly sulfated maltooligosaccharides with heparin-like properties |
| 04/13/1995 | CA2171109A1 Gene therapy of the nervous system |
| 04/13/1995 | CA2148477A1 Further pyrimidine derivatives and their preparation |
| 04/13/1995 | CA2133872A1 Molecules influencing the shedding of the tnf receptor, their preparation and their use |
| 04/13/1995 | CA2133815A1 Inhibition of phosphatidylinositol 3-kinase with viridin, demethoxyviridin, viridiol, demethoxyviridiol, virone, wortmannolone, and analogs thereof |
| 04/12/1995 | EP0647450A1 Improved prodrugs for enzyme mediated activation |
| 04/12/1995 | EP0647270A1 Novel malignant cell type markers of the interior nuclear matrix |
| 04/12/1995 | EP0647266A1 D-enzyme compositions and methods of their use |
| 04/12/1995 | EP0647258A1 Luminescent article with high pigment to binder ratio and manufacture thereof |
| 04/12/1995 | EP0647236A1 Endothelin antagonists ii |
| 04/12/1995 | EP0647219A1 Derivatives in the vitamin d series modified at the 20 position, a method of preparing such derivatives, intermediates used in this method, pharmaceutical preparations containing the derivatives and their use in the preparation of drugs. |
| 04/12/1995 | EP0647135A1 Bis-(substituted-phenyl) derivatives with cytotoxic and anticancer activity |
| 04/12/1995 | EP0329737B1 Tri-aza macrocycles and metal complexes thereof |
| 04/12/1995 | CN1101346A C2 taxane derivatives and pharmaceutical compositions containing them |
| 04/12/1995 | CN1028174C Process and intermediates for preparing compounds having disubstituted acetylene moiety and retinoic acid-like biological activity |
| 04/11/1995 | US5406014 Dehydrogenation processes, equipment and catalyst loads therefor |
| 04/11/1995 | US5405990 Chemical compounds |
| 04/11/1995 | US5405964 Imidazopyridines |
| 04/11/1995 | US5405957 Wavelength-specific photosensitive compounds and expanded porphyrin-like compounds and methods of use |
| 04/11/1995 | US5405938 Sequence-specific binding polymers for duplex nucleic acids |
| 04/11/1995 | US5405866 Multidrug resistance modifying dithianes |
| 04/11/1995 | US5405837 Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin |
| 04/11/1995 | US5405620 Pharmaceutical composition for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases or tumorous origin |
| 04/11/1995 | CA1335201C S-adenosyl methionine inhibitors |
| 04/06/1995 | WO1995009241A2 Anti-cancer gene therapy by modulation of immune or inflammatory response |
| 04/06/1995 | WO1995009180A1 Endothelial monocyte activating polypeptide ii: a mediator which activates host response |
| 04/06/1995 | WO1995009173A1 Anthracycline disaccharides, process for their preparation, and pharmaceutical compositions containing them |
| 04/06/1995 | WO1995009169A1 Process for the preparation of 9-amino camptothecin |
| 04/06/1995 | WO1995009149A1 Anthracene derivatives for use as anticancer agent or dye |
| 04/06/1995 | WO1995009005A1 Methods for stimulating interleukin-6 synthesis and inducing thrombocytopoiesis using oncostatin m |
| 04/06/1995 | WO1995009001A1 Inhibitors of farnesyl-protein transferase |
| 04/06/1995 | WO1995009000A1 Inhibitors of farnesyl-protein transferase |
| 04/06/1995 | WO1995008998A1 Compositions for the prevention and treatment of viral-induced tumors |
| 04/06/1995 | WO1995008991A1 Parenteral busulfan for treatment of malignant disease |
| 04/06/1995 | WO1995008986A1 Camptothecin formulations |
| 04/06/1995 | CA2172958A1 Anthracene derivatives for use as anticancer agent or dye |
| 04/06/1995 | CA2172808A1 Methods for stimulating interleukin-6 synthesis and inducing thrombocytopoiesis using oncostatin m |
| 04/06/1995 | CA2172729A1 Endothelial monocyte activating polypeptide ii: a mediator which activates host response |
| 04/06/1995 | CA2172261A1 Compositions for the prevention and treatment of viral-induced tumors |
| 04/06/1995 | CA2172126A1 Inhibitors of farnesyl-protein transferase |
| 04/06/1995 | CA2172125A1 Inhibitors of farnesyl-protein transferase |
| 04/06/1995 | CA2133281A1 Estradiol derivative-alkylating agent conjugate with reduced hormonal activity, process for preparing the same, compounds useful for the preparation thereof, and growth inhibitingcomposition containing the conjugate or estradiol derivative |
| 04/05/1995 | EP0646600A1 A cell growth-inhibiting protein |
| 04/05/1995 | EP0646592A1 Estradiol derivative-alkylating agent conjugate |
| 04/05/1995 | EP0646578A1 Phenyl carboxamide-isoxazole-derivatives and salts, process for their preparation, their use as pharmaceuticals, and pharmaceutical compositions containing them |
| 04/05/1995 | EP0646576A1 Vitamin D3-analogs |
| 04/05/1995 | EP0646178A1 expression cassette with regularoty regions functional in the mammmlian host |
| 04/05/1995 | EP0646175A1 RECOMBINANT $i(PSEUDOMONAS) EXOTOXIN WITH INCREASED ACTIVITY |
| 04/05/1995 | EP0646132A1 Amino sugars, glycoproteins, method of preparing them, medicines containing them and their use |
| 04/05/1995 | EP0646129A1 Receptor-type tyrosine kinase-like molecules |
| 04/05/1995 | EP0646127A1 Polypeptide bombesin antagonists |
| 04/05/1995 | EP0593639B1 Pyrrolidine and thiazolidine derivatives, preparation thereof and drugs containing same |
| 04/05/1995 | EP0513161B1 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| 04/05/1995 | CN1101046A 2-aminoalkyl-5-aminoalkylamino substituted isoquinoindazole-6(2h)-ones |
| 04/04/1995 | US5403933 Indolizine derivatives, with pharmaceutical activity |
| 04/04/1995 | US5403928 Fluorescent marker components and fluorescent probes |
| 04/04/1995 | US5403858 Perfusion solution ethanol free; antitumor agents |
| 04/04/1995 | US5403851 Substituted tryptamines, phenalkylamines and related compounds |
| 04/04/1995 | US5403713 Administering detectable amount of labeled anti-elam-1 monoclonal antibody and detecting the label |
| 04/04/1995 | CA1335083C Fr901228 substance and preparation thereof |
| 03/30/1995 | WO1995008629A1 Receptor recognition factors, protein sequences and methods of use thereof |
| 03/30/1995 | WO1995008567A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf |
| 03/30/1995 | WO1995008563A1 Glutathione analogs and paralog panels comprising glutathione mimics |
| 03/30/1995 | WO1995008555A1 2',5'-oligoadenylate-2',3'-cyclophosphates |
| 03/30/1995 | WO1995008528A1 Triaryl-ethylene derivatives for use in therapy |
| 03/30/1995 | WO1995008350A1 REGULATION OF bcl-2 GENE EXPRESSION |
| 03/30/1995 | WO1995008326A1 Protein kinase c activators and their use in decreasing expression of cell antigens |
| 03/30/1995 | CA2172490A1 Receptor recognition factors, protein sequences and methods of use thereof |
| 03/30/1995 | CA2172383A1 Protein kinase c activators and their use in decreasing expression of cell antigens |
| 03/30/1995 | CA2172158A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf |
| 03/29/1995 | EP0645397A1 Glutathione analogs and paralog panels comprising glutathione mimics |
| 03/29/1995 | EP0645390A1 Trisubstituted pyrimido 5,4-d pyrimidines for modulating multidrug resistance, drugs containing these compounds and processes for their preparation |
| 03/29/1995 | EP0645376A1 Substituted 1-phenyl-oxazolidin-2-one derivatives, their preparation and their use as adhesion-receptor antagonists |
| 03/29/1995 | EP0645147A1 Determination of lymph nodes enriched in tumor reactive cells, their proliferation, and their use in adoptive cellular therapy |
| 03/29/1995 | EP0645145A2 Stabilized pharmaceutical composition and stabilizing solvent |
| 03/29/1995 | EP0644948A1 Anti-receptor antibodies to the vitamin b12/transcobalamin ii receptor |
| 03/29/1995 | EP0644947A1 Anti-idiotypic monoclonal antibodies against the lewis y-specific monoclonal antibody br55-2 and their uses |
| 03/29/1995 | EP0644933A1 Constitutive and inducible epidermal vector systems |
| 03/29/1995 | EP0644900A1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses |
| 03/29/1995 | EP0644880A1 1,2,3-triazole and imidazole compounds and their antitumor use |
| 03/29/1995 | EP0644759A1 Production and use of imines of porphyrins |
| 03/29/1995 | EP0644716A1 Medical uses of trioxolane and diperoxide compounds |
| 03/29/1995 | EP0558563B1 Anti-inflammatory compounds |
| 03/29/1995 | EP0500602B1 Agent for neutralising the procoagulant activity associated with tumor cells |
| 03/29/1995 | CN1100719A 3-bromo- and 2-nitroxy derivatives of 3-bromo- and 3,3-dibromo-4-oxo, zaetidines, processes for the preparation thereof and use thereof |
| 03/29/1995 | CN1100649A Medicine for relieving inflammation and pain |
| 03/28/1995 | US5401875 2-aminocarboxylic acids and their derivatives, processes for their preparation and their use as medicaments |
| 03/28/1995 | US5401828 Mutant genes present in malignant tumors, detection, tumor specific antibodies for treatment |
| 03/28/1995 | US5401742 Polymeric conjugate of methotrexate compound and pyran copolymer and method for the preparation thereof |
| 03/28/1995 | US5401733 Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol |
| 03/28/1995 | US5401725 Treatment of tumors, rheumatoid arthritis and other diseases caused by vascular hyperplasia |
| 03/28/1995 | US5401724 Therapeutic treatment of chronic myelogenous leukemia by administration of 2-chloro-2'-deoxy adenosine |
| 03/28/1995 | CA2078214C Benzylphosphonic acid tyrosine kinase inhibitors |
| 03/28/1995 | CA1334969C Substituted dihydroisoquinoline and phthalazine derivatives as potentiators of the lethal effects of radiation and certain chemotherapeutic agents, selected compounds, analogs andprocess |
| 03/25/1995 | WO1999013871A2 Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents |